Ausgabe 1/2020
Inhalt (24 Artikel)
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
Rokaya El Ansari, Lutfi Alfarsi, Madeleine L. Craze, Brendah K. Masisi, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer
Jan J. Jobsen, Henk Struikmans, Job van der Palen, Ester Siemerink
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival
Rita A. Mukhtar, Gregor Krings, Yunn-Yi Chen, Matina E. Mamounas, Kelly Fahrner-Scott, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Hope Rugo
LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
Li Pan, Xiang Chen, Shengling Fu, Wenying Yu, Chenglong Li, Tiffany Wang, Hui-Wen Lo, Jiayuh Lin
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
M. J. Hassett, H. Li, H. J. Burstein, R. S. Punglia
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner
Giovanna Panzironi, Giuliana Moffa, Francesca Galati, Flaminia Marzocca, Veronica Rizzo, Federica Pediconi
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
Alessandra Gennari, Flavia Foca, Rita Zamarchi, Andrea Rocca, Dino Amadori, Andrea De Censi, Alessandra Bologna, Luigi Cavanna, Lorenzo Gianni, Laura Scaltriti, Elisabetta Rossi, Antonella Facchinetti, Veronica Martini, Paolo Bruzzi, Oriana Nanni
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients
Antônio Luiz Frasson, Martina Lichtenfels, Alessandra Anton Borba de Souza, Betina Vollbrecht, Ana Beatriz Falcone, Mônica Adriana Rodriguez Martinez Frasson, Fernanda Barbosa
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
Ingeborg J. H. Vriens, Elena M. ter Welle-Butalid, Maaike de Boer, Christine E. M. de Die-Smulders, Josien G. Derhaag, Sandra M. E. Geurts, Irene E. G. van Hellemond, Ernest J. T. Luiten, M. Wouter Dercksen, Bea M. D. Lemaire, Els R. M. van Haaren, Birgit E. P. J. Vriens, Agnes J. van de Wouw, Anne-marie M. G. H. van Riel, Sandra L. E. Janssen-Engelen, Marlène H. W. van de Poel, Ester E. M. Schepers-van der Sterren, Ron J. T. van Golde, Vivianne C. G. Tjan-Heijnen
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
Yvonne Brandberg, Hemming Johansson, Mats Hellström, Michael Gnant, Volker Möbus, Richard Greil, Theodoros Foukakis, Jonas Bergh
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
Hannelore Denys, Corina L. Martinez-Mena, Marc T. Martens, Randal G. D’Hondt, Marie-Pascale L. Graas, Ella Evron, Georgeta Fried, Noa E. Ben-Baruch, Christof Vulsteke, Mona M. Van Steenberghe
Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11C-metformin PET/CT study
Elias Immanuel Ordell Sundelin, Nidal al-Suliman, Pernille Vahl, Mikkel Vendelbo, Ole Lajord Munk, Steen Jakobsen, Steen Bønløkke Pedersen, Jørgen Frøkiær, Lars C. Gormsen, Niels Jessen
Behavior of metastatic breast cancer according to subtype
Margot Van Mechelen, Anke Van Herck, Kevin Punie, Ines Nevelsteen, Ann Smeets, Patrick Neven, Caroline Weltens, Sileny Han, Adriaan Vanderstichele, Giuseppe Floris, Jean-Pierre Lobelle, Hans Wildiers
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma
Wei Liu, Wei Li, Ziyao Li, Lei Shi, Peng Zhao, Zihong Guo, Jiawei Tian, Zhenzhen Wang
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
Whitney L. Do, Karen Conneely, Sheryl Gabram-Mendola, Uma Krishnamurti, Olivia D’Angelo, Jasmine Miller-Kleinhenz, Keerthi Gogineni, Mylin Torres, Lauren E. McCullough
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers
Kristen S. Purrington, David Gorski, Michael S. Simon, Theresa A. Hastert, Seongho Kim, Rayna Rosati, Ann G. Schwartz, Manohar Ratnam
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
Inna Y. Gong, Andrew T. Yan, Craig C. Earle, Maureen E. Trudeau, Andrea Eisen, Kelvin K. W. Chan
The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients
Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Ka Li Cheung, Yi-Qian He, Roselle Lee, Winnie Yeo
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome
Anh N. Le, Joanna Harton, Heena Desai, Jacquelyn Powers, Kristin Zelley, Angela R. Bradbury, Katherine L. Nathanson, Payal D. Shah, Abigail Doucette, Gary M. Freedman, Peter Gabriel, Susan M. Domchek, Suzanne P. MacFarland, Kara N. Maxwell
Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
Takehiro Hirai, Asuka Nemoto, Yoshinori Ito, Masaaki Matsuura
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors
Maria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, Rafael Caparica, Mariana Brandão, Claudia De Angelis, Alain Hendlisz, Ahmad Awada, Martine Piccart, Evandro de Azambuja
A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience
J. Watanabe, M. Saito, Y. Horimoto, S. Nakamoto
Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support
Serena Oliveri, Giulia Ongaro, Ilaria Durosini, Giuseppe Curigliano, Gabriella Pravettoni
HER2 borderline is a negative prognostic factor for primary malignant breast cancer
Atanu Bhattacharjee, Jacinth Rajendra, Rajesh Dikshit, Shilpee Dutt